TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEL AVIV
Loading...
Price History
Market Data
| Market Cap | 33.48B |
| P/E Ratio | 48.65 |
| P/B Ratio | 4.62 |
| EPS | 0.60 |
| Dividend Yield | - |
| D/E Ratio | 4.50 |
| Current Ratio | 1.11 |
| Currency | USD |
Key Financial Metrics
16.78B
Revenue
712.00M
Net Income
0.60
EPS (Diluted)
578.00M
Free Cash Flow
Profitability
Gross Margin
50.1%
Operating Margin
10.9%
Net Profit Margin
4.2%
EBITDA
3.08B
Returns & Efficiency
Return on Assets (ROA)
1.8%
Return on Equity (ROE)
9.8%
Dividend Yield
-
EPS
0.60
Financial Health
Total Assets
39.86B
Total Debt
24.00M
Debt to Equity
4.50x
Current Ratio
1.11
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | TEL AVIV |
| Fiscal Year | 2024 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$33.48B
P/E Ratio (TTM)48.6
Price to Book4.62
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin50.1%
Operating Margin10.9%
Net Margin4.2%
ROE9.8%
ROA1.8%
Leverage & Liquidity
Debt to Equity4.50
Current Ratio1.11
Total Debt$24.00M
Total Assets$39.86B
Stockholders' Equity$7.25B
Income Statement (FY 2024)
Revenue$16.78B
Gross Profit$8.40B
Operating Income$1.83B
Net Income$712.00M
EPS (Diluted)$0.60
Cash Flow (FY 2024)
Free Cash Flow$578.00M
Cash & Equivalents$2.20B
Revenue Growth1.4%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV, None None |
| Phone | 972 (3) 914-8213 |
| Incorporated | None, IL |
| EIN | 000000000 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.15B |
| Stockholders' Equity | $7.25B |
| Cash & Equivalents | $2.20B |
Recent Filings
View All
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-29
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-03-31
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-03-31
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-03-31
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-19
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | TEVA PHARMACEUTICAL INDUSTRIES LTD |
| Ticker | TEVJF |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | TEL AVIV |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 33.48B |
| Revenue | 16.78B |
| Net Income | 712.00M |
| P/E Ratio | 48.65 |
| EPS | 0.60 |
| Net Margin | 4.2% |
| ROE | 9.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...